Glenn F. Tilton, Director at AbbVie Inc. (ABBV), bought 10,800 shares at $91.90 ($993K) on 2018-06-27, disclosed to the SEC on 2018-06-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.90 | 5,400 | $496K | 50.0% |
| 2 | $91.90 | 5,400 | $496K | 50.0% |
| Total | $91.90 avg | 10,800 | $993K | 100% |
| Filing → |
| UAL | SELL | 2013-01-09 | $1.5M | — | Filing → |
| UAL | SELL | 2013-01-04 | $1.4M | — | Filing → |
| UAL | SELL | 2012-06-01 | $2.2M | — | Filing → |